Median Diagnostics Inc. (XKON:233250)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,000
0.00 (0.00%)
At close: Feb 27, 2026
Market Cap17.47B -31.0%
Revenue (ttm)7.86B +40.4%
Net Income-567.58M
EPS-496.00
Shares Out1.75M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2
Average Volume16
Open10,000
Previous Close10,000
Day's Range10,000 - 10,000
52-Week Range9,400 - 16,600
Beta0.14
RSI36.40
Earnings Daten/a

About Median Diagnostics

Median Diagnostics Inc. manufactures and sells veterinary medicines and diagnostic reagents. The company’s products include PCR sets for pigs, ruminants, poultry, equine, canine and feline, and shrimps; rapid kits for pigs, ruminants, poultry, canine, feline, erwinia amylovora, and bovine pregnancy; ELISA for pigs, ruminants, avians, and horses; standard reagents, including AGID, HI, and FA; and antigen/antibody, including antibodies for veterinary diagnostics, and antibodies and antigens for human diagnostics. It also offers mouse and rat path... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1999
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 233250
Full Company Profile

Financial Performance

Financial Statements